DIN ISO 13022:2014 Edition

$49.40

Medical products containing viable human cells – Application of risk management and requirements for processing practices

Published By	Publication Date	Number of Pages
DIN	2014-06	54

Guaranteed Safe Checkout

Categories: 11.100.20 - Biological evaluation of medical devices, DIN

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

Description

This standard specifies a procedure to identify the hazards and hazardous situations and to manage the risk associated with viable cellular component (s) of products regulated as medicals products, biological, medical devices and active implantable medical devices or combination thereof. It covers viable human materials of autologous as well allogenic human origin. For the manufacturer of medical products containing viable cells of human origin, this standard specifies a procedure to identify the hazards and hazardous situations associated with such cells, to estimate and evaluate the resulting risks, to control this risk, and to monitor the effectiveness of the control. Furthermore the standard outlines the decision process for the residual risk acceptability, taking into account the balance of residual risk, and expected medical benefit as compared to available alternatives.

Additional information

Published Code	DIN
Published By	Deutsches Institut für Normung
Publication Date	2014-06
Pages Count	54
Language	Germany
Descriptors	Cells, Cells (biology), Definitions, Documentation, Drugs, Handling, Human biology, Human body, Human medicine, Implants (surgical), Medical devices, Medical products, Risk analysis, Risk management, Specification (approval), Workplace safety, Medicine
File Size	860.2 KB
ICS Codes	11.100.20 - Biological evaluation of medical devices

Preview PDF


PDF Format	Searchable	Printable	Preview Now

DIN ISO 13022:2014 Edition

Related products